Active Ingredient History
Heparin, also known as unfractionated heparin (UFH), is a medication and naturally occurring glycosaminoglycan. Heparin is a blood anticoagulant that increases the activity of antithrombin. It is used in the treatment of heart attacks and unstable angina. It can be given intravenously or by injection under the skin. Its anticoagulant properties make it useful to prevent blood clotting in blood specimen test tubes and kidney dialysis machines. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute Lung Injury (Phase 1/Phase 2)
Anticoagulants (Phase 4)
Aortic Stenosis, Subvalvular (Phase 4)
Bleeding Time (Phase 3)
Blood Coagulation Disorders (Phase 4)
Blood Component Removal (Phase 4)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 2)
Coronavirus Infections (Phase 4)
COVID-19 (Phase 4)
Critical Illness (Phase 2)
DNA Mismatch Repair (Phase 1/Phase 2)
Extracorporeal Membrane Oxygenation (Phase 4)
Gram-Negative Bacterial Infections (Phase 3)
Hemorrhage (Phase 4)
Heparin (Phase 3)
Hypertrophy, Left Ventricular (Phase 4)
Leukemia, Lymphoid (Phase 4)
Myocardial Infarction (Phase 4)
Myocardial Ischemia (Phase 2)
Pneumonia, Viral (Phase 3)
Pulmonary Embolism (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Respiratory Insufficiency (Phase 2/Phase 3)
Sepsis (Phase 3)
Severe Acute Respiratory Syndrome (Phase 3)
Shock (Phase 2)
Shock, Septic (Phase 2)
Stroke (Phase 4)
Thrombosis (Phase 4)
Traumatology (Phase 4)
Venous Thromboembolism (Phase 4)
Ventricular Dysfunction, Right (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue